Background: Maximum exercise workload (W MAX ) is today assessed as the first part of Cardiopulmonary Exercise testing. The W MAX test exposes patients with COPD, often having cardiovascular comorbidity, to risks. Our research project was initiated with the final aim to eliminate the W MAX test and replace this test with a predicted value of W MAX , based on a prediction algorithm of W MAX derived from multicentre studies. Methods: Baseline data (W MAX , demography, lung function parameters) from 850 COPD patients from four multicentre studies were collected and standardized. A prediction algorithm was prepared using Random Forest modelling. Predicted values of W MAX were used in a new W MAX test, which used a linear increase in order to reach the predicted W MAX within 8 min. The new W MAX test was compared with the standard stepwise W MAX test in a pilot study including 15 patients with mild/moderate COPD. Results: The best prediction algorithm of W MAX included age, sex, height, weight, and six lung function parameters. FEV 1 and DLCO were the most important predictors. The new W MAX test had a better correlation (R 2 = 0.84) between predicted and measured W MAX than the standard W MAX test (R 2 = 0.66), with slopes of 0.50 and 0.46, respectively. The results from the new W MAX test and the standard W MAX test correlated well. Conclusion: A prediction algorithm based on data from four large multicentre studies was used in a new W MAX test. The prediction algorithm provided reliable values of predicted W MAX . In comparison with the standard W MAX test, the new W MAX test provided similar overall results. ARTICLE HISTORY
Introduction
Spirometry is mandatory for establishing a diagnosis of chronic obstructive pulmonary disease (COPD) but is not sufficient for a general clinical assessment and evaluation of potential treatment effects. Functional performance assessed at walk or bicycle exercise tests together with measurements of symptoms and healthrelated Quality of Life (QoL) provide valuable additional information about present disease status, as well as prediction of future risk of exacerbations and disease prognosis [1] [2] [3] [4] [5] [6] [7] . The standard bicycle exercise protocol for cardiopulmonary exercise testing (CPET) measures the endurance time of cycling during a standard endurance test, at a constant rate of 75% of the maximum exercise workload (W MAX ) [7] [8] [9] [10] [11] . W MAX is obtained in a preceding incremental W MAX test, in which the patient is subjected to a stepwise increase in workload until the point of physical exhaustion or another symptom-limited reason for stopping is reached.
CPET is technically demanding and requires expensive equipment [11] . A considerable number of participants are needed to detect potential therapeutic effect differences due to high inter-and intra-test variability of the standard endurance test [8, 10, 12, 13] . In addition, CPET is associated with a certain increase in cardiac risks, particularly at the initial W MAX test [7, 8] .
A way to address the above downsides would be to correctly predict W MAX , which optimally could avoid the W MAX test by using 75% of the predicted value for the endurance test. Several papers have identified predictors for W MAX or maximal oxygen consumption (VO2 MAX ) in COPD patients using the standard W MAX or VO 2MAX test. Forced expiratory volume in 1 sec (FEV 1 ) has been identified as an important predictor [14] [15] [16] [17] [18] [19] . Other predictors identified are static lung volumes (e.g. inspiratory capacity; IC) [14, 15, 18] , small airway dysfunction, e.g. reduced mid-expiratory flow (FEF ) [17, 20, 21] , impaired gas exchange measured by e.g. diffusing capacity for carbon monoxide (DLCO) [14, 15, 18, 20, 22] , maximal voluntary ventilation (MVV) [18, 19, 21] , Medical Research Council (MRC) scale [16, 17] , sub-maximal exercise [23, 24] and demographic data such as sex, age, body-mass index (BMI) or fat-free mass [14] [15] [16] [17] 20, 21, 25] . However, another article concluded that predicted VO 2MAX from baseline characteristics cannot be used for patients with stable COPD [26] .
Previous papers claiming predictability of W MAX (VO 2MAX ) had different reasons for trying to replace the incremental test by a predictive (W MAX or VO 2MAX ) value, e.g. to determine an individual patient's future risks of, e.g., exacerbations, to avoid complication in a cardiopulmonary risk population, to reduce costs caused by expensive equipment and to achieve a reasonably accurate endurance value for a rehabilitation program. Only one study [27] has specifically addressed the possibility to predict the individual incremental step increase to keep the test to 8-10 min (see also [16, 28] ). Most previous prediction papers have used stepwise and not linear increase. A number of older studies concluded that a linear ramp test was no better than a stepwise incremental test (for an overview, see [8] ), but these papers could be challenged.
We, therefore, embarked on a research project aiming to improve CPET by (1) 
Materials and methods
Studies used for developing a prediction algorithm of W MAX
Patients
Baseline data (demography, lung function parameters and W MAX from incremental exercise tests) were provided from two pharmaceutical companies (AstraZeneca and Boehringer Ingelheim) via standard data-sharing agreements. Patients with COPD participated in four multicentre, randomised clinical studies examining the effects of tiotropium (Study A,B,D) [12, 13, 29] or budesonide/ formoterol (Study C) [30] on exercise performance ( Table 1 ). The inclusion criteria were similar in Study A-C, while Study D included patients with milder COPD. Patients were clinically stable patients with COPD, aged >40 years, with a smoking history of >10 pack-years, a prebronchodilator FEV 1 ≤ 65% (Study A and B) of predicted normal, ≤50% (Study C) or 50-80% (Study D). Studies were approved by medical ethical committees and all patients gave written informed consent before undertaking any study procedures.
Study design
In Study, A-D eligibility criteria were assessed during an initial screening visit. At this or a following prerandomization visit, patients performed pulmonary function tests followed by a standard incremental W MAX test. Study A-C were conducted using bicycle exercise testing while Study D used treadmill exercise testing.
The data were combined into a single dataset following transformations in order to account for differences in units, data formats and naming of the variables. Note that all variables were not available from all studies.
Outcome measures
For the post hoc analysis of Study A-D, the outcome was a prediction algorithm for the best possible prediction of W MAX .
Statistical analyses
Prediction algorithms were formulated using Random Forest modelling [31] for each of Study A-D separately. The Random Forest model was used to automatically handle potential non-linear associations among the variables (predictors). A list of the ranking order among the variables was obtained, sorted in descending order with the best predicting variable first. Random Forest modelling was performed using R (v 3.5.1 for Mac) software. Univariate regression was performed in Microsoft Excel for Office 365. The Random Forest algorithms are available for external use upon request.
Pilot study to compare new and standard W MAX test

Patients
In the pilot study, patients with COPD who had no exacerbations of COPD within the last 6 weeks, a postbronchodilator FEV 1 of ≥40 to ≤80% of predicted normal and no cardiovascular co-morbidity preventing exercise testing were included. The Regional Ethical Review Board approved the study. Written informed consent was obtained from all patients prior to any study procedures. Patients were out-patients who had previously visited our clinic and registered for volunteering in other research studies. Values are mean ± standard deviation unless otherwise specified. AZ, AstraZeneca; BMI, Body-mass index; BI, Boehringer Ingelheim; FEV1, forced expiratory volume in 1 sec; FVC, Forced vital capacity; ICS, Inhaled corticosteroid; LABA, Long-acting β2 adrenoceptor agonist; LAMA, Long-acting muscarinic receptor antagonist. * 80% had COPD duration >5 years; 20% had COPD duration 2-5 years ** Pre-bronchodilator (Study A-D); post-bronchodilator (Pilot study). *** % of predicted normal, calculated according to NHANES III.
Study design
The study was non-blinded and single-centre. At visit 1, demography data, modified medical research council (MMRC) dyspnea scale scores and clinical COPD questionnaire (CCQ) scores were collected. The COPD patients performed lung function tests (spirometry, body plethysmography, CO-diffusion test and impulse oscillometry) after inhalation of 400 µg salbutamol. The predicted value of W MAX for each patient was calculated on a pre-programmed computer holding the Random Forest algorithm.
Patients then performed the standard or the new W MAX test in a random cross-over fashion at the following visits. During the standard test, after a few minutes of sitting on the bicycle in order to stabilize the oxygen kinetics measurement equipment, the patient had an approximately one-minute warm-up period of loadless pedalling, followed by an incremental increase in workload with 10 W per minute until the patient reached his/her W MAX at the point of exhaustion. During the new W MAX test, the patients started cycling at a load of 40% of the predicted W MAX for 3 min, followed by a linear increase in load, calculated to reach the predicted W MAX after an additional 8 min ( Figure 1 ). In both W MAX tests, the same safety procedure were applied, as recommended for the standard W MAX test [7, 8] . Borg scale results were collected at every 2 min during both tests [32] .
Outcome measures
The primary outcome measure was the ability of the prediction algorithm to successfully predict W MAX as shown by the coefficient of determination (R 2 ) between predicted and measured W MAX at the new W MAX test. Secondary outcome variables were descriptive comparisons between the new and the standard W MAX test for averages of measured W MAX and work performed, reasons for stopping exercise and Borg scale results.
Statistical analyses
We designed the study to include 15-20 patients in order to obtain enough data to test the prediction model and to compare the new test with the standard test, but no formal power calculation was performed. The comparisons between predicted and measured W MAX , and the new and the standard W MAX test were performed using univariate regression, descriptive statistics and Bland-Altman graphs [33] . Microsoft Excel for Office 365 was used for univariate regression analyses and Bland-Altman graphs. Demographics and patient data were expressed as mean ± standard deviation.
Results
Studies used for developing a prediction algorithm of W MAX In total, 850 patients with COPD were included in the dataset for Study A-D, and their baseline data are summarized in Table 1 . Using Random Forest modelling, all lung function and demographic variables for each of Study A-D were assessed for their ability to predict W MAX . Results are presented in Table 2 . The best percentage of variance explained was obtained for Study A, followed by Study B, C and D. The six best Table 3 . Table 3 shows that DLCO, together with FEV 1 , was the best predictor in Study A. It was decided to base the prediction algorithm on the results from this study only, since the other study with measurements of DLCO (Study D) was a study using treadmill walking in patients with mild COPD. The lung function variables listed above from Study A were selected for the prediction algorithm, together with age, sex, height and weight. The results from the prediction algorithm are presented in the Figure 2 , where predicted W MAX has been plotted versus measured W MAX for Study A. An R 2 -value of 0.95 and a slope of 0.77 was observed.
Pilot study to compare new and standard W MAX test
Patient population
A total of 19 patients were enrolled between July and October 2015. Fifteen of these were included in the study. Three were excluded due to FEV1 ≥ 80% pre- dicted and one due to significant cardiovascular comorbidity. Fifteen patients with COPD were included in the pilot study. They had a mean age of 71 years and mean FEV 1 was 60% predicted normal. Further patient baseline characteristics are presented in Table 1 .
Ability of the prediction algorithm to predict W MAX Figure 3 shows the correlation of predicted W MAX versus measured W MAX for the two tests (Figure 3(a,b) ) plus the corresponding Bland-Altman plots (Figure 3(c,d) (Table 4 ). For W MAX reached (Figure 4 , part A) and work performed in kWs (Figure 4, part B 
Discussion
In our search for a prediction algorithm with the ability to accurately predict W MAX to a level where standard incremental W MAX test can be eliminated, we investigated baseline lung function and demographic data together with results from a standard incremental W MAX test from four large pharmaceutical industrysponsored clinical studies. Since DLCO was found to have outstanding abilities for prediction of W MAX , a prediction algorithm was built using Random Forest modelling of data from only one of these four studies, a multicentre study with 261 patients. FEV 1 was another an excellent predictor, as was also observed in the three remaining studies, but these studies either lacked measurements of DLCO or used treadmill rather than bicycle exercise testing. The obtained prediction algorithm was utilized to set the low-intensity start and the linear increase in , respectively, indicating that, for both tests, W MAX in the high range obtained from high performers are underestimated by the prediction algorithm and that W MAX in the low range (low performers) are overestimated by the prediction algorithm. The conformity was best for patients with mid-range W MAX values and hence the prediction algorithm needs further improvement. An improved prediction algorithm would improve the precision of the new W MAX test, so that the endurance test will be performed at an optimal level. If the patient starts the endurance test at too low or too high values as derived from the W MAX test, too long or too short endurance times may be observed leading to an increased intra-test variability.
The two tests correlated well with measured W MAX, but the new linear test gave continuous data (not 10W stepwise data) along the regression line and achieved the predicted value of W MAX in 9.3 ± 2.4 min (programmed value 8 min), which meant that the increase was adapted to the respective individual. This resulted in a higher amount of performed work with less deviation. The Values are mean ± standard deviation unless otherwise specified. * Excluding the initial 3 min bicycling at 40% of predicted W MAX ** Including the initial 3 min bicycling at 40% of predicted W MAX *** Reported as dyspnea, leg discomfort, both of these or other reasons standard test and the new test showed similar mean W MAX . but the amount of work performed in kWs was constantly higher for the new method for both low and high performers. This is partly explained by the initial 3 min of bicycling at 40% of W MAX , but this accounts only for some 30-40% of the difference. The rest of the difference may be explained by the individualized increase in work overtime. In the standard test the load started at 10 W (but can be 30-40 W based on the experience of the investigator). The incremental steps were 10 W (but steps from 5 to 20 W have been utilized), and higher increases than 10 W have been pointed out to be beneficial [8] . In the new test, the initial low load and the following linear increase to W MAX are personalized. The bicycle is programmed to reach the predicted W MAX in 8 min; i.e. a predicted high performer faces a much steeper increase than a predicted low performer. Also, the precision of W MAX is lower in the standard test, since work performed is calculated based on 10W-increments. This is exemplified in Figure 3 where five patients have a measured W MAX of 100 W in the standard test. A large number of prediction formulas for W MAX or VO 2MAX in COPD patients have been presented [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] 27, 28] . Most of these have been derived from singlecentre studies with low numbers of patients, and the generalizability of these formulas to broader COPD populations and to multicentre studies can be questioned. We took another approach by using data from large multicentre studies sponsored by pharmaceutical companies. The resulting prediction algorithm might be more accurate and generalizable as compared to most previous prediction equations of W MAX due to the bigger and broader COPD populations included in the analyses. However, the multicentre data includes many centres with different qualities in performing a correct W MAX test. For DLCO, problems with standardisation across centres and large coefficients of variation have been observed [34] . A good and generalizable prediction algorithm could be helpful to achieve the best possible measured W MAX in order to have the 75% level in the endurance test as accurate as possible.
One of our major learnings is that the single and multicentre approach identified very similar predictors. Our prediction algorithm identified FEV 1 (flow), DLCO (gas-exchange), FVC and VA (volume), FEF 50 (small airways) and demographic data, which agrees well with previous publications [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] 27, 28] . One study [26] criticised the use of baseline lung function to predict VO 2MAX However, this study selected six prediction formulas from three papers [14, 15, 22] of which four included transplant candidates and one very severe COPD patients while the validation was done in 60 COPD-patients equally divided into GOLD 2, 3 and 4. Other papers have not challenged the possibility of predicting W MAX or VO 2MAX . However, Fregonezi [26] highlight a very important issue of all prediction models, i.e. generalisability, both related to disease severity and quality of assessment between centres.
The current study has a number of limitations. The prediction algorithm has been based on multicentre studies with high variability. Only one study was finally used as some of the key variables for prediction have not been collected in the other studies. A limitation with Random Forest is the non-intuitive relationship between the different variables making a judgement based on clinical knowledge important. In addition, Random Forest is usually applied to larger sample sizes. In the studies, the measurements of W MAX and the demographic parameters were well documented but other good predictors had a lower quality or were missing (e.g. DLCO). The prediction algorithm does not account for differences in the level of activity among the patients, and whether the patients have little or much experience from bicycling. Also, the low number of patients in the pilot study makes the results from this study sensitive to the performance by individual patients.
Areas for further improvements of the prediction algorithm include QoL-variables, variables measuring daily activities, oxygen kinetic data and values from examinations of small airway functions such as impulse oscillometry measures. The possible role of hyperinflation as predictors in more severe patients should also be explored [35] .
In summary, a prediction algorithm for W MAX has been developed from incremental exercise bicycle tests in previously published multicentre clinical studies. The best predictors were FEV 1 and DLCO. A new linear W MAX test including the use of the prediction algorithm correlated well with the standard incremental W MAX test. The new W MAX test had a better correlation to the prediction algorithm, even though the algorithm was developed from the standard W MAX test. In addition, an improved prediction algorithm with a slope closer to line-of-identity will benefit the new W MAX test. Therefore, the new test will be utilized in future studies within our research project until the prediction algorithm has reached a level of precision that enables the W MAX test to be replaced with a predicted value of W MAX .
